Nymox Pharmaceutical Corp
(NASDAQ : NYMX)

( )
NYMX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
-5.36%504.002.4%$505.78m
ABTAbbott Laboratories
-3.06%70.560.8%$502.14m
MDTMedtronic PLC
-1.80%92.660.6%$470.09m
TMOThermo Fisher Scientific Inc.
-2.98%236.211.0%$462.22m
ALGNAlign Technology, Inc.
-7.91%217.296.3%$430.00m
BDXBecton, Dickinson and Company
-2.89%236.241.1%$319.89m
BSXBoston Scientific Corporation
-4.35%36.921.1%$292.12m
EWEdwards Lifesciences Corporation
-3.55%147.751.2%$288.38m
BAXBaxter International Inc.
-3.04%61.551.7%$270.89m
ABMDABIOMED, Inc.
-16.61%337.863.3%$249.32m
SYKStryker Corporation
-0.75%169.971.3%$238.61m
DXCMDexCom, Inc.
-5.12%141.818.5%$182.32m
ZBHZimmer Biomet Holdings, Inc.
-2.76%114.381.7%$149.01m
WATWaters Corporation
-2.03%195.403.4%$144.20m
IDXXIDEXX Laboratories, Inc.
-4.03%198.823.7%$125.01m

Company Profile

Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.